Improving HIV Care for Young People with Technology
Comprehensive, tailored, technology-based intervention to improve virologic suppression among youth and young adults living with HIV
This project is testing a personalized, technology-based program to help young people with HIV stay healthy and manage their treatment effectively.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-11138452 on NIH RePORTER |
What this research studies
Many young people living with HIV face challenges like starting and sticking with their medication, staying in care, and managing mental health or substance use issues. This project aims to create a "youth-friendly" approach to address these barriers. We are testing a personalized program that uses technology, including brief weekly counseling sessions, to help young adults aged 18-29 improve their health outcomes. The goal is to make it easier for them to stay on track with their HIV care and achieve viral suppression.
Who could benefit from this research
Good fit: Ideal candidates are youth and young adults aged 18-29 living with HIV who may be struggling with medication adherence, staying in care, or managing mental health and substance use challenges.
Not a fit: Patients outside the 18-29 age range or those not living with HIV would not directly benefit from this specific program.
Why it matters
Potential benefit: If successful, this program could help young people with HIV better manage their condition, improve their overall health, and reduce the risk of complications.
How similar studies have performed: While the influence of mental health and substance use on HIV outcomes is well-known, this intervention offers a novel, tailored, technology-based approach specifically for youth and young adults.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Saberi, Parya — University of California, San Francisco
- Study coordinator: Saberi, Parya
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.